At least 5% of individuals with hypertension have adrenal aldosterone-producing adenomas
(APAs). Gain-of-function mutations in KCNJ5 and apparent loss-of-function mutations in …

Primary aldosteronism is the most common form of secondary hypertension. Mutations in
the KCNJ5 gene have been described recently in aldosterone-producing adenomas (APAs). …

Background: The parathyroid hormone (PTH) stimulates aldosterone secretion and cell
proliferation in human adrenocortical cells; moreover, in rats hyperaldosteronism was associated …

Primary aldosteronism (PA) is a common cause of second-ary hypertension, because it involves
11.2% of referred hypertensive patients. 1 Primary hyperparathyroidism (PPTH) is much …

Coronavirus Disease 2019 (COVID‐19) has infected more than 3.0 million people worldwide
and killed more than 200,000 as of April 27, 2020. In this White Paper, we address the …

Hyperparathyroidism represents as a novel feature of primary aldosteronism (PA). Its occurrence
in patients with the surgically correctable aldosterone-producing adenoma (APA) and …

Several drugs can cause hypertension and/or blunt the effect of antihypertensive treatment.
They can exacerbate a previously well controlled hypertension and/or render it resistant to …

Lifestyle modifications are one of the cornerstones of hypertension prevention and treatment.
We aimed to systematically review hypertension guidelines on their recommendations on …

Background A stress reaction involving increased cortisol release, which has not been
documented thus far, might affect the assessment of selectivity of catheterization during adrenal …

Background The COVID-19 pandemic may disproportionately affect the mental health of
healthcare professionals (HCPs), especially patient-facing HCPs. Aims To longitudinally …